Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Use of Antibiotics After Hospital Discharge in Septic Abortion (APA)
This study has been terminated.
Sponsored by: Hospital de Clinicas de Porto Alegre
Information provided by: Hospital de Clinicas de Porto Alegre
ClinicalTrials.gov Identifier: NCT00353743
  Purpose

The use of antibiotics in post-partum infection has been abbreviated. After 48 hours of clinical improvement, the patient is discharged from the hospital without antibiotics. No trials has been found in cases of septic abortion.

The purpose of the present study is to verify the need of antibiotics after clinical improvement in cases of septic abortion.


Condition Intervention
Abortion, Septic
Drug: placebo
Drug: doxycycline plus metronidazole

MedlinePlus related topics: Antibiotics
Drug Information available for: Doxycycline Doxycycline calcium Doxycycline hyclate Metronidazole Metronidazole hydrochloride Metronidazole phosphate
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Parallel Assignment, Efficacy Study
Official Title: A Randomized Clinical Trial on the Use or Not of Antibiotics After Hospital Discharge in Septic Abortion.

Further study details as provided by Hospital de Clinicas de Porto Alegre:

Primary Outcome Measures:
  • Clinical cure defined as no fever, no abdominal pain or bleeding. [ Time Frame: 10 days after hospital discharge ] [ Designated as safety issue: Yes ]

Enrollment: 56
Study Start Date: May 2006
Study Completion Date: December 2007
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
Patients that receive up to 10 days of doxycycline 200mg/day and metronidazole 500mg/day
Drug: doxycycline plus metronidazole
doxycycline 200mg/day plus metronidazole 500mg/day up to 10 days of treatment (additional to the hospital treatment)
2: Placebo Comparator
Patients that do not receive antibiotics, only placebo
Drug: placebo
placebo

Detailed Description:

Septic abortion is still a major cause of maternal mortality in developing countries. According to the WHO, 1 woman dies for every 270 illegal abortion (Ahman E, 2004). Infected abortion has an important role in maternal morbidity and mortality (Stubblefield PG, 1994). the diagnosis of infected abortion must be considered when a patient presents a history of delayed menses, vaginal bleeding, abdominal pain and fever (Brasil, 2000)

Prompt diagnosis and treatment are paramount steps to prevent complications. At Hospital de Clínicas de Porto Alegre, the use of gentamycin plus clindamicin before curettage is preconized (Savaris R, 2006). Nevertheless, the time of treatment it is not well established, varying from 7-14 days (Brasil, 2000).

A recent study with post-partum endometritis has shown that it is not necessary to extend the treatment to 14 days, after clinical improvement (Turnquest MA, 1998; French LM, 2004)

A randomized clinical trial comparing placebo with the standard protocol of treatment would define weather both treatments are equivalent or not.

Comparison: The prolonged use of antibiotics, after intravenous use of antibiotics and clinical improvement, will be compared to the use of placebo in cases of septic abortion.

Sample size and ethical issues The study protocol was approved by the ethics committee of Hospital de Clínicas de Porto Alegre.

To compare equivalence between the 2 treatments we calculated the sample size considering an alpha error of 0.05, a beta error of 0.1, and difference between the two groups of no more than 10%. We expected a 99% clinical cure with the standard protocol, and 95% for the alternative one. These figures yield a minimum of 42 patients in each group. Interim analysis will performed at 58 for possible early stopping, if clinical cure was < 95%, or for sample size re-estimation.

Randomization and treatment Subjects will be allocated in blocks of four at a time to create the allocation sequence. If the patient was eligible for the study, she will be allocated to one of the 2 treatments. The allocation will be concealed, coded and obtained from a central telephone number. Patients and those who assessed the outcomes were blind to group assignment. To avoid bias, both medications were manipulated by the hospital pharmacy and put in identically coded blisters and capsules.

Statistical analysis Student´s t-test, Mann-Whitney test, and Fisher´s exact test will be used for statistical analysis. The rates of cure were analyzed by "modified" intention to treat (Keech AC, 2003) and per protocol with 95% confidence intervals.

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients admitted at the hospital with a diagnosis of infected abortion and about to be discharged from the hospital.
  • Use of intravenous antibiotics (gentamicin and clindamycin)
  • Improvement of the clinical conditions for at least 48 hours (no fever, eating and walking normally, reduced vaginal bleeding)

Exclusion Criteria:

  • Unwilling to participate in the study.
  • Use of antibiotics previously within one week.
  • Presence of tubo-ovarian abscess.
  • Known allergy to doxycycline or metronidazole.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00353743

Locations
Brazil, Rio Grande do Sul
Hospital de Clínias de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-003
Sponsors and Collaborators
Hospital de Clinicas de Porto Alegre
Investigators
Principal Investigator: Ricardo F Savaris, MD, PhD Hospital de Clínicas de Porto Alegre
  More Information

location of the study  This link exits the ClinicalTrials.gov site

Publications:
Responsible Party: HCPA-UFRGS ( Ricardo Francalacci Savaris )
Study ID Numbers: 05-452, GPPG 05-452
Study First Received: July 13, 2006
Last Updated: December 18, 2008
ClinicalTrials.gov Identifier: NCT00353743  
Health Authority: Brazil: Ministry of Health

Keywords provided by Hospital de Clinicas de Porto Alegre:
infected abortion
treatment period
doxycycline
metronidazole
placebo

Study placed in the following topic categories:
Metronidazole
Abortion, Septic
Pregnancy Complications
Pregnancy Complications, Infectious
Abortion, Spontaneous
Doxycycline

Additional relevant MeSH terms:
Antimalarials
Anti-Infective Agents
Anti-Bacterial Agents
Antiparasitic Agents
Antiprotozoal Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Physiological Effects of Drugs
Infection
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009